letrozole   Click here for help

GtoPdb Ligand ID: 5209

Synonyms: Femara®
Approved drug
letrozole is an approved drug (FDA (1997))
Compound class: Synthetic organic
Comment: Letrozole is an oral non-steroidal aromatase (CYP19A1) inhibitor, with anti-estrogen action.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 0
Rotatable bonds 3
Topological polar surface area 78.29
Molecular weight 285.1
XLogP 2.47
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES N#Cc1ccc(cc1)C(n1cncn1)c1ccc(cc1)C#N
Isomeric SMILES N#Cc1ccc(cc1)C(n1cncn1)c1ccc(cc1)C#N
InChI InChI=1S/C17H11N5/c18-9-13-1-5-15(6-2-13)17(22-12-20-11-21-22)16-7-3-14(10-19)4-8-16/h1-8,11-12,17H
InChI Key HPJKCIUCZWXJDR-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
Approved for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Aromatase (CYP19A1) inhibitors suppress the aromatization of androgens into estrogens. In postmenopausal women this action can have an anti-proliferative effect on the growth of estrogen-responsive cancers.